Computer-Aided Detection (CAD): A US & European Market Report
San Jose, CA (Vocus) June 10, 2010
Computer-aided detection (CAD) has developed rapidly since 1998, when R2 Technology received the first CAD license from the US FDA for industrial application of the ImageChecker™. Technological advancements have resulted in increasing application of CAD in other types of cancer diagnosis. CAD is not just confined to being a collaborative tool in mammography studies, but has expanded its horizons to become an extensive support tool for detecting lung, pancreas and colon cancer. Rising awareness about cancer detection in the early stages, and increasing focus on the impact of changing lifestyles is expected to enhance the significance of CAD technology.
Breast CAD applications account for a predominant 85% share of the total sales in the US Computer-Aided Detection market, as stated by the new market research report on Computer-Aided Detection (CAD) market. The use of CAD technique in combination with mammography has been found to lower the risk of observational errors by up to 20%. Such improvement lessens expenses, and enhances effectiveness of treatment procedures, thereby improving patient survival rates. The European Breast CAD market is forecast to exceed US$140 million by 2013.
Rising incidence of lung cancer and the role of early detection in preventing mortality are expected to fuel adoption of Chest CAD. Currently, Chest CAD has been confined to CT studies due to the laborious and time-intensive process of data analysis associated with the rising number of slices. The advent of newer software products for identification of nodules in the lungs is expected to boost prospects owing to the fact that chest x-rays represent the most common diagnostic tool. The market for Colon CAD, although a nascent market, is expected to benefit from the increasing screening initiatives undertaken by various governments, particularly in Europe.
CAD market is dominated by the presence of few large players. In the CAD mammography segment, iCAD and Hologic, are the two large players, while Carestream Health, Inc. is emerging as a major contender. Key players profiled in the report include Carestream Health Inc., FUJIFILM Medical Systems, GE Healthcare, Hologic Inc., iCAD Inc., Invivo Corporation, Merge Healthcare Incorporated, Philips Healthcare, and Siemens Healthcare.
The report titled “Computer-Aided Detection (CAD): A US & European Market Report” announced by Global Industry Analysts, Inc., provides a review of market trends, cancer incidence statistics, product introductions/innovations, and recent industry activity. The study analyzes market data and analytics in terms of annual sales (value and volume) for the US and European markets by the following Application segments- Breast, Chest, and Colon.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/